CLDX
Price
$19.58
Change
+$0.15 (+0.77%)
Updated
Apr 24 closing price
Capitalization
1.3B
6 days until earnings call
CLYM
Price
$1.30
Change
-$0.04 (-2.99%)
Updated
Apr 24 closing price
Capitalization
87.72M
24 days until earnings call
Ad is loading...

CLDX vs CLYM

Header iconCLDX vs CLYM Comparison
Open Charts CLDX vs CLYMBanner chart's image
Celldex Therapeutics
Price$19.58
Change+$0.15 (+0.77%)
Volume$452.68K
Capitalization1.3B
Climb Bio
Price$1.30
Change-$0.04 (-2.99%)
Volume$110.08K
Capitalization87.72M
CLDX vs CLYM Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. CLYM commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Buy and CLYM is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CLDX: $19.58 vs. CLYM: $1.30)
Brand notoriety: CLDX and CLYM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 57% vs. CLYM: 48%
Market capitalization -- CLDX: $1.3B vs. CLYM: $87.72M
CLDX [@Biotechnology] is valued at $1.3B. CLYM’s [@Biotechnology] market capitalization is $87.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileCLYM’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • CLYM’s FA Score: 1 green, 4 red.
According to our system of comparison, CLYM is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 5 TA indicator(s) are bullish while CLYM’s TA Score has 4 bullish TA indicator(s).

  • CLDX’s TA Score: 5 bullish, 3 bearish.
  • CLYM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than CLYM.

Price Growth

CLDX (@Biotechnology) experienced а +6.99% price change this week, while CLYM (@Biotechnology) price change was +3.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

CLDX is expected to report earnings on Aug 07, 2025.

CLYM is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.3B) has a higher market cap than CLYM($87.7M). CLDX YTD gains are higher at: -22.517 vs. CLYM (-27.778). CLYM has higher annual earnings (EBITDA): -24.57M vs. CLDX (-191.9M). CLDX has more cash in the bank: 725M vs. CLYM (193M). CLYM has less debt than CLDX: CLYM (58K) vs CLDX (3.81M). CLDX has higher revenues than CLYM: CLDX (7.02M) vs CLYM (0).
CLDXCLYMCLDX / CLYM
Capitalization1.3B87.7M1,482%
EBITDA-191.9M-24.57M781%
Gain YTD-22.517-27.77881%
P/E RatioN/AN/A-
Revenue7.02M0-
Total Cash725M193M376%
Total Debt3.81M58K6,574%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXCLYM
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
60%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 18 days ago
80%
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDDVX18.76N/A
N/A
BlackRock Equity Dividend Inv A
ARYMX12.69N/A
N/A
American Century Global Real Estate A
MERIX17.44N/A
N/A
The Merger Fund I
NWXUX9.61N/A
N/A
Nationwide International Sm Cp R6
KESGX14.33N/A
N/A
Kennedy Capital ESG SMID Cap I

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+0.77%
BEAM - CLDX
51%
Loosely correlated
+1.51%
DNLI - CLDX
51%
Loosely correlated
+4.17%
KYMR - CLDX
49%
Loosely correlated
+9.32%
NTLA - CLDX
48%
Loosely correlated
+1.11%
RVMD - CLDX
47%
Loosely correlated
+3.04%
More

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with RLYB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
-2.99%
RLYB - CLYM
40%
Loosely correlated
+0.47%
ELVN - CLYM
36%
Loosely correlated
+2.98%
MNMD - CLYM
33%
Poorly correlated
+5.24%
CLDX - CLYM
32%
Poorly correlated
+0.77%
LRMR - CLYM
32%
Poorly correlated
+4.87%
More